Cardiac decompensation

3 papers1 finding

Animals1

Interventions

1

Empagliflozin

downin humans1

1 study

Empagliflozin decreases cardiac decompensation in humans.
“and to reduce episodes of cardiac decompensation”
Review
Empagliflozin in the elderly
Geriatrie et psychologie neuropsychiatrie du vieillissement16 Dec 2021

More on Empagliflozin

Latest

2 in 12 months

AHA Scientific Sessions 2025 Abstract3 Nov

Temporal and Demographic Trends in Mortality Among Patients with Intracranial Bleed and Concurrent Heart Failure: A 25-Year Analysis Using the CDC WONDER Database (1999–2024)

Study in peoplePopulations

AHA Scientific Sessions 2025 Abstract3 Nov

Combination Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapy Reduces Admissions and Death in Patients with Heart Failure with Reduced Ejection Fraction

Study in peopleInterventions

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement16 Dec

Empagliflozin in the elderly

ReviewEmpagliflozin

Geriatrie et Psychologie Neuropsychiatrie du Vieillissement1 Jun

Empagliflozin in the elderly

ReviewEmpagliflozin

Science Translational Medicine10 Feb

Nicotinamide for the treatment of heart failure with preserved ejection fraction

Experiments in miceHeart failure with preserved ejection fraction